SIETES :: 93059 citas

Resultados de la búsqueda por CAPTOPRIL REFINAR BÚSQUEDA

1.

Azzouz B, Morel A, Kanagaratman L, Herlem E, Trenque T. Psoriasis after exposure to angiotensin-converting enzyme inhibitors: French pharmacovigilance data and review of the literature. Drug Saf 2019;42:diciembre. [Ref.ID 103209]

2.

Anónimo. Spironolactone - potion or poison?. Drug Ther Bull 2017;55:13. [Ref.ID 101402]

3.

Bangalore S, Fakheri R, Wandel S, Toklu B, Wandel J, Messerli FH. Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials. BMJ 2017;356:j4. [Ref.ID 101389]

4.

Anónimo. Drugs past their expiration date. JAMA 2016;315:510-1. [Ref.ID 100021]

5.

Anónimo. Hypertension artérielle essentielle chez un adulte: premiers traitements. Prescrire 2015;35:683-6. [Ref.ID 99722]

6.

Anónimo. Drugs past their expiration date. Med Lett Drugs Ther 2015;57:164-5. [Ref.ID 99690]

7.

Anónimo. Traitement de l'hypertension artérielle essentielle. Un diurétique thiazidique en premier choix, le plus souvent. Prescrire 2014;34:275-81. [Ref.ID 97442]

8.

Anónimo. Atteintes des ongles d'origine médicamenteuse. Prescrire 2014;34:191-4. [Ref.ID 97362]

9.

Anónimo. Drug-induced liver injury. Australian Prescriber 2013;36:168-9. [Ref.ID 96320]

10.

Gao Y, O'Caoimh R, Healy L, Kerins DM, Eustace J, Guyatt G, Sammon D, Molloy DW. Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia. BMJ Open 2013;3:22 de julio. [Ref.ID 95839]

11.

Anónimo. Neuropathies périphériques d'origine médicamenteuse. Prescrire 2013;33:269-75. [Ref.ID 95342]

12.

Anónimo. Candesartan. Fetal malformations. Australia. WHO Pharmaceuticals Newsletter 2012;4:4. [Ref.ID 93675]

13.

Anónimo. Candesartan, fetal malformations and use in pregnancy. Australian Prescriber 2012;35:98. [Ref.ID 92635]

14.

Chang C, Gershwin ME. Drug-induced lupus erythematosus. Incidence, management and prevention. Drug Saf 2011;34:357-74. [Ref.ID 90404]

15.

Arroll B, Doughty R, Andersen V. Investigation and management of congestive heart failure. BMJ 2010;341:190-5. [Ref.ID 88929]

16.

Bonet Monné S. Dades d'eficàcia dels IECA, ARA II i la combinació d'ambdós grups de fàrmacs. Butlletí d'Informació Terapèutica 2010;22:7-12. [Ref.ID 88270]

17.

Montero Corominas D, García del Pozo J, de Abajo FJ. Utilización de antihipertensivos en España, 1992-2006. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2009:1-14. [Ref.ID 86455]

18.

Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Golf Jr DC. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension. Results from the Cardiovascular Health Study. Arch Intern Med 2009;169:1195-202. [Ref.ID 86332]

19.

Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009;373:240-9. [Ref.ID 85048]

20.

Clark DWJ, Coulter DM, Besag FMC. Randomized controlled trials and assessment of drug safety. Drug Saf 2008;31:1057-61. [Ref.ID 84722]